NeoPhore raised £9.6m in extended Series B funding from CPF (Sixth Element Capital), Claris Ventures, Astellas Venture, 3B Future Health Fund, 2investAG.

Biotech Health services

Investments

02 January 2024

NeoPhore (company)

Biotech Health services

Total investments received (USD): 40.71m

Round value (USD): 12.2m

Round investors: 3B Future Health Fund Astellas Venture Management Neva SGR Claris Ventures 2invest Sixth Element Capital

Company: NeoPhore

Industry: Biotech Health services

Biotech Health services Pharma

Investments 19 June 2024

Biotech Hardware Health services Manufacturing

Investments 02 May 2024

Biotech Health services

Investments 01 March 2024

Biotech Health services Software Services

Investments 14 January 2024

AI (big data) Biotech Health services Software Services

Investments 13 December 2023